{"date":"2026-01-30","count":26,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6550-2026-01-30-2233-15fp5p3","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-01-30","time":"22:33:31","subject":"本公司決議終止非酒精性脂肪肝炎臨床收案及試驗，將資源聚焦其他更有效益的臨床發展計畫。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-01-30 22:33，「本公司決議終止非酒精性脂肪肝炎臨床收案及試驗，將資源聚焦其他更有效益的臨床發展計畫。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-01-30-2233-12lbxpc","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-01-30","time":"22:33:02","subject":"本公司決議終止肝癌臨床收案及試驗，將資源聚焦其他更有效益的臨床發展計畫。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-01-30 22:33，「本公司決議終止肝癌臨床收案及試驗，將資源聚焦其他更有效益的臨床發展計畫。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-01-30-1934-1irikix","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-01-30","time":"19:34:26","subject":"公告本公司114年12月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-01-30 19:34，「公告本公司114年12月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2026-01-30-1830-19q8zho","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2026-01-30","time":"18:30:21","subject":"公告本公司114年度現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜","clause":"第45款","fact_date":"2026-01-30","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2026-01-30 18:30，「公告本公司114年度現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2026-01-30-1829-11vxjjv","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2026-01-30","time":"18:29:54","subject":"本公司114年現金增資股款催繳公告","clause":"第51款","fact_date":"2026-01-30","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2026-01-30 18:29，「本公司114年現金增資股款催繳公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-01-30-1824-1la4lt7","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-30","time":"18:24:51","subject":"公告本公司購置不動產案相關事宜(簽訂買賣契約)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-01-30 18:24，「公告本公司購置不動產案相關事宜(簽訂買賣契約)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-01-30-1746-nj73a9","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-01-30","time":"17:46:48","subject":"代子公司承業長照社團法人公告向關係人取得使用權資產","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-01-30 17:46，「代子公司承業長照社團法人公告向關係人取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2026-01-30-1648-d8h6pu","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2026-01-30","time":"16:48:34","subject":"公告本公司一年內累積取得同一有價證券達實收資本額百分之二十","clause":"第17款","fact_date":"2026-01-30","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2026-01-30 16:48，「公告本公司一年內累積取得同一有價證券達實收資本額百分之二十」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-01-30-1646-n5286r","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-01-30","time":"16:46:08","subject":"本公司代子公司米香食品股份有限公司公告法人董事異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-01-30 16:46，「本公司代子公司米香食品股份有限公司公告法人董事異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-01-30-1642-1owqrxb","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-01-30","time":"16:42:39","subject":"代子公司欣大首美達股份有限公司公告向關係人取得使用權資產","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-01-30 16:42，「代子公司欣大首美達股份有限公司公告向關係人取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-01-30-1638-101cnxf","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-01-30","time":"16:38:43","subject":"召開本公司一一五年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-01-30 16:38，「召開本公司一一五年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-01-30-1637-92x690","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-01-30","time":"16:37:16","subject":"董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-01-30 16:37，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2026-01-30-1634-ae1eci","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2026-01-30","time":"16:34:09","subject":"公告本公司董事會決議召開115年度股東常會相關事宜","clause":"第17款","fact_date":"2026-01-30","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2026-01-30 16:34，「公告本公司董事會決議召開115年度股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-01-30-1614-1qwz7qj","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-01-30","time":"16:14:39","subject":"公告本公司於董事會通過民國一一四年度個體財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-01-30 16:14，「公告本公司於董事會通過民國一一四年度個體財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-01-30-1612-17rcl13","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-01-30","time":"16:12:31","subject":"公告本公司於董事會通過民國一一四年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-01-30 16:12，「公告本公司於董事會通過民國一一四年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-01-30-1603-1vwfknh","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-01-30","time":"16:03:37","subject":"公告本公司董事會補選委任薪酬委員會委員一席","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-01-30 16:03，「公告本公司董事會補選委任薪酬委員會委員一席」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2026-01-30-1557-1pzjlpi","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-30","time":"15:57:55","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2026-01-30 15:57，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-01-30-1552-a7i57n","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-01-30","time":"15:52:59","subject":"公告本公司114年現金增資延長特定人繳款期限","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-01-30 15:52，「公告本公司114年現金增資延長特定人繳款期限」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-01-30-1526-nthf30","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-01-30","time":"15:26:34","subject":"(更正1/29公告)公告本公司治理主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-01-30 15:26，「(更正1/29公告)公告本公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2026-01-30-1521-84656m","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2026-01-30","time":"15:21:54","subject":"公告本公司董事會通過內部稽核主管任命案","clause":"第11款","fact_date":"2026-01-30","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2026-01-30 15:21，「公告本公司董事會通過內部稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-01-30-1512-1pzjlpi","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-01-30","time":"15:12:56","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-01-30 15:12，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2026-01-30-1503-100esni","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2026-01-30","time":"15:03:18","subject":"公告本公司研發主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2026-01-30 15:03，「公告本公司研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-01-30-1458-u1wxx6","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-01-30","time":"14:58:06","subject":"公告本公司114年第四季自結損益","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-01-30 14:58，「公告本公司114年第四季自結損益」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-01-30-1456-1f7tf35","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-01-30","time":"14:56:04","subject":"公告本公司114年12月份自結合併財務報告之負債比率、流動比率及速動比率","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-01-30 14:56，「公告本公司114年12月份自結合併財務報告之負債比率、流動比率及速動比率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2026-01-30-1344-54swv6","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2026-01-30","time":"13:44:50","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2026-01-30","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2026-01-30 13:44，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-01-30-0839-usi1ve","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-01-30","time":"08:39:32","subject":"本公司股票即將終止興櫃交易並轉至臺灣證券交易所上市交易","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-01-30 08:39，「本公司股票即將終止興櫃交易並轉至臺灣證券交易所上市交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}